02Health & Science
Research
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
Jan 10IGM Biosciences slides by 66% on discontinued drug development and lay offsNov 29Battery Metals market to grow 47% to US$25.3B by 2031: InsightAceJun 29CBN significantly improves sleep disturbances: FloraWorks studyMay 4Young men at highest risk of schizophrenia linked to cannabis use: studyNov 17Flora Growth builds lab in Bogota, offers acne treatments
Feb 5Biogen ends 17-Year Aduhelm alzheimer's drug studyOct 671% of Canadian women say inflation is taking a toll on their mental health: MHRC surveyJun 20PharmaTher Holdings enters collaboration to commercialize racemic ketamineFeb 14Non-hormonal contraceptive temporarily inhibits movement in sperm cells: studyNov 9Canadians worried about inflation but will spend on gifts this season: CPA survey
Jan 4DEA sharply increases quantities of psychedelics, cannabinoids for 2024 researchAug 1Rio Tinto launches $132M research centre for sustainable critical minerals extraction methodsJun 15Microdosing LSD could help you sleep better: MindBio TherapeuticsNov 28Rolls-Royce and easyJet complete world's first run of a hydrogen-powered aircraft engineNov 1Terpenes and cannabinoids more efficient as anti-inflammatories than NSAIDs: Gb Sciences study
Page 3
Have a story we should be covering? Tips, corrections and pitches are welcome.
Contact the desk